Bone Metastasis as the Initial Presentation in one Case of Ovarian Cancer With Two Components of Endometrioid Adenocarcinoma and Adenosarcoma  by Chen, Yi-Lin et al.
Taiwan J Obstet Gynecol • September 2009 • Vol 48 • No 3
■ RESEARCH LETTER ■
298
Ovarian cancer with bone metastasis is relatively rare
(about 1.2%) [1], compared with direct extension,
transperitoneal seeding and lymphatic spread. Bone
metastasis of ovarian cancer is mostly found during
recurrence, and is very rare at the initial diagnosis with
only a few cases reported [2]. We report a case with
the initial diagnosis of advanced ovarian cancer with
thoracispinal metastasis, and discuss the differential
diagnosis and clinical course.
A 48-year-old women gravida 2, para 1, had suffered
from mid-back pain for 4 months. She had iron-
deficiency anemia because of menorrhagia. She visited
a gynecologic clinic for regular Papanicolaou tests and
pelvic examinations annually. The only abnormal finding
was adenomyosis using ultrasound in October 2005.
She did not have changes in appetite, decreased body
weight or bowel movement changes. However, her back
pain had been present since October 2005. She visited a
neurologic clinic in our hospital in February 2006, and
an osteolytic lesion in the pedicle of T7 was noticed on
an X-ray film of the spine. High signals in the pedicles
of T7 and L3 and soft tissue around T7 on magnetic
resonance imaging were found (Figure 1). Her CA 125
level was 102.22 U/mL and CA 199 was 98.3 U/mL.
She underwent T2–T8 laminectomy and excision of a
tumor in February 2006. Pathologic findings revealed
metastatic poorly differentiated carcinoma with glan-
dular differentiation. Postoperative follow-up revealed
normal findings on chest X-ray, panendoscopy and
colonofiberscopy, and a large left ovarian multicystic
tumor measuring approximately 15×10 cm adhered
to her uterus and adenomyosis of the uterus on the
computed tomography scan (Figure 2).
In March 2006, she underwent exploratory laparo-
tomy, and a left ovarian cystic tumor measuring approx-
imately 14×11×8 cm, which adhered to her uterus,
bowel, retroperitoneum and left fallopian tube, and
some ascites, were found intraoperatively. The frozen
pathology during the operation revealed ovarian malig-
nancy. Abdominal total hysterectomy, bilateral salpingo-
oophorectomy, bilateral pelvic lymph node dissection
and infracolic omentectomy were performed. There was
no residual tumor in the abdominal and pelvic cavity
after surgery. Grossly, the left ovary showed a huge
unilocular cystic tumor, which measured 6.5×5.0×
2.0 cm after cystic content evacuation, with a polypoid
solid nodule protruding from the cystic wall into the
cystic cavity. The final microscopic finding showed: (1)
left ovarian adenosarcoma with predominant rhab-
domyosarcomatous differentiation over the solid part,
and grade I endometrioid adenocarcinoma with squa-
mous differentiation over the cystic part with deep,
irregular invasion over the gland (Figure 3); (2) multiple
lymph node metastasis; and (3) carcinoma in situ of the
cervix. Based on the histologic and immunohistologic
findings (i.e. positive for CK7, focally patchy positive for
p16, negative for CK20 and TTF-1), the lesion in the
vertebral body was consistent with a metastatic lesion
from ovarian endometrioid adenocarcinoma.
Under the diagnosis of ovarian cancer with tho-
racispinal metastases, she received palliative radiother-
apy for bone metastasis, and systemic chemotherapy
with one cycle of carboplatin (area under the curve,
6 mg/mL · min) and paclitaxel (175 mg/m2) initially.
The chemotherapy regimen was then changed to six
courses of doxorubicin (50 mg/m2) and ifosfamide
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(5 g/m2) for 21 days per cycle (from April 5, 2006 to
July 20, 2006) because of her anaphylactic reaction to
paclitaxel. Progressively decreased values of CA 125
(from 102.22 U/mL in February 2006 to 43.7 U/mL in
July 2006) were noted. However, an emergency opera-
tion with posterior decompression, instrumentation and
fixation at T5 to T9 was performed for multiple thora-
columbar spinal compression fractures and impending
paraplegia in October 2006. In addition, a large amount
of ascites and a huge pelvic tumor were found. Nonethe-
less, this patient refused further chemotherapy and re-
ceived palliative therapy only. She died from septic
shock in November 2006.
Ovarian epithelial malignancies usually spread by
direct extension, transperitoneal seeding or lymphatic
spread. Distant metastases present only in 8% of the
patients at the time of diagnosis, and 22% of the patients
present with distant metastases during the course of the
disease [1]. Ovarian epithelial malignancies metastasize
to the skeletal system at an incidence of only 0.7–14%
(Table) [1–12], and bone metastasis is a late stage issue,
which is rare at the initial diagnosis [2]. Only a few cases
with bone metastasis have been reported at the initial
presentation in patients with ovarian cancer [10,13]. We
also performed a retrospective chart review from January
2005 through December 2006 in our hospital, and only
our current case was found to have an initial presenta-
tion with bone metastasis among 90 ovarian cancer
patients.
The median time to development of bone metastasis
after the diagnosis of stage I–III ovarian cancer was 74
months (range, 68–80 months) [1]. Therefore, bone
metastasis in this case may reflect its aggressive nature
despite the status of grade 1 endometrioid adenocar-
cinoma. Bone metastases in patients with ovarian car-
cinoma are usually associated with symptoms of bone
pain. The lesions tend to be focal and osteolytic, rarely
osteoblastic [14]. The vertebral bodies are the most
common site of metastasis, followed by the ribs, clavicle,
skull, and femur [11]. In addition, the osteolytic spinal
lesions of this case were similar to the most common
findings of the bone lesions resulting from ovarian
cancer metastasis. All histologic types of ovarian cancer
can metastasize to the bones, and the most frequent is
epithelial ovarian carcinoma. Serous cystadenocarci-
noma (15%) had been reported as the most common
histologic type of gynecologic cancer with bone metas-
tasis, followed by mucinous cystadenocarcinoma (12%)
and endometrioid adenocarcinoma (10%) [4]. However,
no reports were available in the literature that mentioned
bone metastasis in patients with ovarian adenosarcoma.
The mean survival interval was 7.5 months (range,
6–39 months) in patients with bone metastasis of
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Figure 1. (A) Magnetic resonance imaging of the thoracic spine revealed a bone lesion (arrows) at T7 with epidural involvement;
(B) another bone lesion was found at L3 (arrow).
Figure 2. Abdominal and pelvic computed tomography scan
revealed a huge heterogeneous mass (large arrow) adhered to
the right superior aspect of uterus. Tumor invasion to the deep
myometrium was also found (small arrows).
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ovarian cancer [7,11,12]. The survival interval of 10
months in this case was within the reported range.
Metastatic bone tumors in women mostly originated
from breast cancer, followed by lung, kidney and thyroid
cancer. Metastatic bone tumors which originate from
gynecologic cancer are rare [15,16]. However, we rec-
ommend a careful investigation, such as pelvic exami-
nation, Papanicolaou test and ultrasound of pelvic
organs, in women with metastatic bone lesions to avoid
missed or delayed diagnosis and treatment.
In conclusion, we present a rare case of ovarian cancer
with two components of endometrioid adenocarcinoma
and adenosarcoma with an initial presentation of
bone metastasis. Poor prognosis was noted despite
aggressive treatment.
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